TMS Co (TSE:4891) Total Stockholders Equity: 円2,410.31 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4891 TMS Co Ltd TSE:4891
31 GF Score
Price 円132.00
! 2 Warning Signs
View Full Analysis

What is TMS Co Total Stockholders Equity?

TMS Co TSE:4891 +3.13% 31 Total Stockholders Equity is 円2,410.31 Mil as of Jun. 2026. GuruFocus rates TSE:4891 with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

TMS Co's Total Stockholders Equity for the quarter that ended in Jun. 2026 was 円2,410.31 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. TMS Co's Book Value per Share for the quarter that ended in Jun. 2026 was 円52.78. The ratio of a company's debt over equity can be used to measure how leveraged this company is. TMS Co's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.00.

TMS Co  (TSE:4891) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

TMS Co's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(2410.313-0)/45.666557
=52.78

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

TMS Co's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 2410.313
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMS Co Total Stockholders Equity Related Terms

TMS Co Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for TMS Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMS Co Total Stockholders Equity Chart

TMS Co Annual Data
Trend Feb21 Feb22 Feb23 Feb24 Dec25
Total Stockholders Equity
1,126.89 2,453.00 3,714.05 3,457.07 2,771.13

TMS Co Quarterly Data
Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,988.27 2,788.42 2,815.49 2,580.53 2,410.31
TSE:4891
31GF Score
TMS Co Ltd TSE:4891
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of 円2,410.31 Mil mean?
TMS Co (TSE:4891) has a Total Stockholders Equity of 円2,410.31 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for TMS Co and its competitors.
Is TMS Co's Total Stockholders Equity too high?
TMS Co's current Total Stockholders Equity is 円2,410.31 Mil. Overall, TMS Co has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does TMS Co's Total Stockholders Equity compare to VRTX and REGN?
TMS Co's Total Stockholders Equity of 円2,410.31 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for TMS Co and its competitors. TMS Co's current Total Stockholders Equity is 円2,410.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMS Co stock overvalued right now?
TMS Co (TSE:4891) has a current Total Stockholders Equity of 円2,410.31 Mil. The current Total Stockholders Equity is 円2,410.31 Mil. TMS Co's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For TMS Co (TSE:4891), the current Total Stockholders Equity is 円2,410.31 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TMS Co Business Description

Address 1-9-11F, Fuchu-cho, Fuchu-shi, Tokyo, JPN, 183-0055
TMS Co Ltd is focused on researching, developing, manufacturing, and selling pharmaceuticals. The company is involved in conducting research and development of SMTP compounds, which are drug candidate substances targeting soluble epoxide hydrolase (sEH), an enzyme found in the human body. It is developing sEH inhibitors for various inflammatory diseases. The company's clinical pipeline comprises three compounds: TMS-007 (being developed as a potential treatment for acute cerebral infarction), which is in the late clinical stage, TMS-010, and JX09 (for resistant and poorly controlled hypertension) and TMS-008 (to target acute inflammatory diseases such as kidney injury and cancer cachexia), which are in the early clinical stage. In addition, it has TMS-009 as a backup compound for TMS-008.
31GF Score

Get the complete analysis for TSE:4891

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円132.00
Price